SCHEMBL28518019

SCHEMBL28518019

CCCCCSc1ncc(C(=O)O)c(NCc2ccccc2)n1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.62
AGTR1 P30556 5/20 0.48
AGTR2 P50052 5/20 0.48
KDM5B Q9UGL1 3/20 0.45
KDM6B O15054 2/20 0.45
KDM4A O75164 2/20 0.45
KDM4D Q6B0I6 2/20 0.45
KDM3B Q7LBC6 2/20 0.45
HIF1AN Q9NWT6 2/20 0.45
KDM2A Q9Y2K7 2/20 0.45
NPC1 O15118 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
RAB9A P51151 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PLK1 P53350 1/20 0.44
HDAC3 O15379 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28522378 0.90 PPARG (0.56) PPARGAGTR1AGTR2NPC1CYP1A2
SCHEMBL28518879 0.89 SMN1; SMN2 (0.58) PPARGAGTR1AGTR2NPC1CYP1A2
SCHEMBL1522370 0.82 PPARG (0.62) PPARGAGTR1AGTR2KDM5BKDM6B
SCHEMBL34462302 0.78 AGTR1 (0.51) PPARGAGTR1AGTR2KDM5BMAPT
SCHEMBL1014882 0.73 RAB9A (0.42) KDM5BKDM6BKDM4AKDM4DKDM3B
SCHEMBL12904539 0.73 STAT6 (0.58) PPARG
SCHEMBL28524818 0.72 ALDH1A1 (0.42) NPC1MAPTRAB9ASMN1; SMN2HDAC3
SCHEMBL445955 0.72 ALDH1A1 (0.65) PPARGNPC1CYP1A2CYP2D6MAPT
SCHEMBL16824948 0.70 KDM4E (0.54) PPARG
SCHEMBL2894732 0.70 AGTR2 (0.53) AGTR1AGTR2KDM5BKDM6BKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106279044-B Pyrimidine hydroxamic acid derivative and preparation method and application thereof 厦门市博瑞来医药科技有限公司 2021-02-19 CN disclosed